Direct Discharge of Patients With Upper Gastrointestinal Bleeding From the Emergency Department After Endoscopy
NCT ID: NCT03337256
Last Updated: 2020-04-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
762 participants
INTERVENTIONAL
2015-09-01
2026-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Endoscopic Diagnosis and Treatment of Acute Nonvariceal Upper Gastrointestinal Bleeding
NCT04895904
Factors Predicting the Need for Endoscopic Intervention in Non-variceal Upper Gastrointestinal Bleeding
NCT05979025
To Compare a Hemostatic Powder TC-325 and Standard Treatment in the Control of Acute Upper Gastrointestinal Bleeding From Nonvariceal Causes
NCT02534571
Endoscopic Findings in Patients With Upper GIT Bleeding
NCT06886880
Single-use Versus Reusable Gastroscopes in Patients With Upper Gastrointestinal Bleeding.
NCT06192355
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Suitable patients attending the Accident \& Emergency Department for symptoms of upper gastrointestinal bleeding will be identified and recruited by the Accident \& Emergency physicians. Patients presenting to Endoscopy Centre after admission will also be recruited to collect clinical data.
Univariate analysis was carried out on the development set using Pearson's chi-square method to examine the association among the factors on the outcome. Variables significantly associated with 30 day re-attendance rate in univariate analyses (P\<=0.1) will be entered in multivariate logistic regression models. Risk factors which retained significance in multivariate analyses will be selected for incorporation into the risk score. A weighting will be assigned to each independent variable in the risk score, applying the corresponding adjusted odds ratio (AOR). The risk score for each subject is the sum of all the risk factors. To evaluate the predictive ability of the scoring system, a receiver operating characteristic (ROC) curve was constructed and the area under the curve (AUC) was delineated. A concordance (c)-statistics was used to reflect the discriminative ability of the prediction tool.
Cost-effective economical model will be used in cost effective analysis of the use of early discharge strategy.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
GI bleeding score
Early endoscopy in emergency department + other clinical parameters
GI bleeding score
Risk factor Score component value Age (years) 15-29 -2 30-44 -1.5 45-59 0 60-74 1.5
* 75 2.5 Haemoglobin(g/L)
* 10.0 0 \<9.9 2 Systolic blood pressure (mmHg)
* 110 0 90-109 1.5 \<90 2.5 Pulse (beats per min) \<100 0
* 100 1.5 Creatinine (mmol/L) \<200 0
* 200 3.5 Number of blood transfusion 0 0
1 1.5
* 2 2 Presenting symptom Melaena -1.5 Drug treatment Acid blcoking drug 1.5 anticoagulant 3 Endoscopy findings Clean-based ulcer -2 SRH or blood in stomach 4 Varices 5
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
GI bleeding score
Risk factor Score component value Age (years) 15-29 -2 30-44 -1.5 45-59 0 60-74 1.5
* 75 2.5 Haemoglobin(g/L)
* 10.0 0 \<9.9 2 Systolic blood pressure (mmHg)
* 110 0 90-109 1.5 \<90 2.5 Pulse (beats per min) \<100 0
* 100 1.5 Creatinine (mmol/L) \<200 0
* 200 3.5 Number of blood transfusion 0 0
1 1.5
* 2 2 Presenting symptom Melaena -1.5 Drug treatment Acid blcoking drug 1.5 anticoagulant 3 Endoscopy findings Clean-based ulcer -2 SRH or blood in stomach 4 Varices 5
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Age \<18 years old
3. Pregnancy
4. Medically unfit to receive an upper endoscopy procedure (require O2 supplement \>3L/min, persistent haemodynamic instability despite initial resuscitation, mental confusion)
5. Require admission to intensive care unit
6. Require emergency endoscopy for uncontrolled gastrointestinal bleeding
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese University of Hong Kong
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aric Josun Hui
Conultant-in-charge, Combined Endoscopy Unit, Alice Ho Miu Ling Nethersole Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Aric Josun Hui, MD
Role: PRINCIPAL_INVESTIGATOR
Chinese University of Hong Kong
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Alice Ho Miu Ling Nethersole Hospital
Hong Kong, , Hong Kong
Prince of Wales Hospital
Hong Kong, , Hong Kong
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
GIB Score 002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.